AMBALAL SARABHAI ENTERPRISES
Back to Balance Sheet
|
AMBALAL SARABHAI ENTERPRISES Last 5 Year Sundry Debtors History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Sundry Debtors | ₹48 Cr | ₹44 Cr | ₹26 Cr | ₹27 Cr | ₹28 Cr |
What is the latest Sundry Debtors ratio of AMBALAL SARABHAI ENTERPRISES ?
| Year | Sundry Debtors |
|---|---|
| Mar2026 | ₹48 Cr |
| Mar2025 | ₹44 Cr |
| Mar2024 | ₹26 Cr |
| Mar2023 | ₹27 Cr |
| Mar2022 | ₹28 Cr |
How is Sundry Debtors of AMBALAL SARABHAI ENTERPRISES Trending?
| Years | Sundry Debtors | % Change | |
|---|---|---|---|
| Mar2026 | ₹48 Cr | 8.07 | |
| Mar2025 | ₹44 Cr | 68.10 | |
| Mar2024 | ₹26 Cr | -3.94 | |
| Mar2023 | ₹27 Cr | -2.58 | |
| Mar2022 | ₹28 Cr | - | |
Compare Sundry Debtors of peers of AMBALAL SARABHAI ENTERPRISES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| AMBALAL SARABHAI ENTERPRISES | ₹324.9 Cr | -4.2% | -9% | 33.7% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹455,826.0 Cr | -1.6% | -2.5% | 21.4% | Stock Analytics | |
| DIVIS LABORATORIES | ₹247,019.0 Cr | 1.5% | 12.8% | 48.7% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹186,875.0 Cr | -0.9% | -0.8% | 35.3% | Stock Analytics | |
| CIPLA | ₹112,773.0 Cr | -1.6% | -5.2% | -11.7% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹95,570.9 Cr | -2.2% | -2.3% | -8.2% | Stock Analytics | |
AMBALAL SARABHAI ENTERPRISES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| AMBALAL SARABHAI ENTERPRISES | -4.2% |
-9% |
33.7% |
| SENSEX | -1.1% |
-3.6% |
-5.3% |
You may also like the below Video Courses